Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.benzinga.com/analyst-stock-ratings. INSM initiated with $192 PT.
Top Wall Street analysts changed their outlook on these top names.
For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
BMO Capital analyst Connor Mackay initiated coverage on Insmed Inc (NASDAQ:INSM) with an Outperform rating and announced a price target of $192.
Insmed shares closed at $107.02 on Monday.
See how other analysts view this stock.
Top Wall Street analysts changed outlook on top names. Analyst rating changes include upgrades, downgrades, and initiations. See…
Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page for full coverage.
Top Wall Street analysts change outlook on top names. See analyst ratings page for changes, including…
Top Wall Street analysts changed outlook on top names. See analyst ratings page for upgrades, downgrades, and initiations. Check…
Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's analyst ratings page. See analyst…
Wall Street analysts change outlook on top names. Check analyst ratings page for all changes. See what analysts say about LYEL,…
